Michael Nally - 04 Mar 2026 Form 4 Insider Report for Generate Biomedicines, Inc. (GENB)

Role: Chief Executive Officer, Director
Signature: /s/ Michael Wolf, Attorney-in-Fact
Issuer symbol: GENB
Transactions as of: 04 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Mar 2026, 16:55:18 UTC
Previous filing: 26 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nally Michael	Chief Executive Officer, Director	GENERATE BIOMEDICINES, INC., 101 SOUTH STREET, SUITE 900, SOMERVILLE	/s/ Michael Wolf, Attorney-in-Fact	06 Mar 2026	0001763945

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GENB	Common Stock	Purchase		+20,000	+3.6%	$12.00	572,707	04 Mar 2026	Direct
holding	GENB	Common Stock						1,316,654	04 Mar 2026	By MTN 2024 GST Trust	F1
holding	GENB	Common Stock						999,793	04 Mar 2026	By MTN 2024 GRAT	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.